Vivos Therapeutics (VVOS) Current Assets (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Current Assets of $4.8 million for Q1 2026, up 33.6% year-over-year from $3.6 million in Q1 2025, and up 9.92% quarter-over-quarter from $4.4 million in Q4 2025.
Vivos Therapeutics (VVOS) Current Assets (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Current Assets for 8 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 33.6% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (up 33.6% YoY), while the FY2025 annual figure was $4.4 million, down 41.34% from the prior year.
- Current Assets improved to $4.8 million in Q1 2026 per VVOS's latest filing, from $4.4 million in the prior quarter.
- Across five years, Current Assets topped out at $21.6 million in Q1 2022 and bottomed at $2.0 million in Q3 2023.
- Historically, Current Assets has averaged $7.2 million across 5 years, with a median of $5.8 million in 2025.
- Annual changes were most pronounced in 2022 — Current Assets sank 80.15% — and 2024, when it soared 272.75%.
- Vivos Therapeutics' Current Assets stood at $5.4 million in 2022, then tumbled by 54.63% to $2.5 million in 2023, then soared by 203.66% to $7.5 million in 2024, then tumbled by 41.34% to $4.4 million in 2025, then rose by 9.92% to $4.8 million in 2026.
- Business Quant data shows VVOS's Current Assets at $4.8 million in Q1 2026, $4.4 million in Q4 2025, and $5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 4.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.82 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | 5.79 Mn |
| Jun 30, 2025 | 6.73 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 7.47 Mn |
| Sep 30, 2024 | 7.40 Mn |
| Jun 30, 2024 | 7.85 Mn |
| Mar 31, 2024 | 3.61 Mn |
| Dec 31, 2023 | 2.46 Mn |
| Sep 30, 2023 | 1.99 Mn |
| Jun 30, 2023 | 5.34 Mn |
| Mar 31, 2023 | 8.71 Mn |
| Dec 31, 2022 | 5.42 Mn |
| Sep 30, 2022 | 9.70 Mn |
| Jun 30, 2022 | 15.51 Mn |
| Mar 31, 2022 | 21.60 Mn |
| Dec 31, 2021 | 27.32 Mn |
| Sep 30, 2021 | 34.03 Mn |
| Jun 30, 2021 | 39.39 Mn |